Home
Kevin Michael Krause, Chief Strategy Officer: AN2 Therapeutics ANTX Sell · Filed 24/01/04
Trade details
- Type
- Insider sale
- Amount
- $51,969.96
- Shares · price
- 2,583 sh · $20.12 a share
- Held after
- 1,914 sh
- Trade date
- 24/01/02
- Filed
- 24/01/04
- Days to filing
- 2 days
Sold 57.4% of holdings
- Share of holding sold
- 57.4%
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/03~24/02/01Kevin Michael Krause's recent trades
- Kevin Michael Krause
Sell10b5-1 planAN2 Therapeutics
Sell10b5-1 planAN2 Therapeutics
ANTX
$149.4K
7,417 sh
$149.4K
Filed 24/01/11
Traded 24/01/09